Tag Archives: healthcare

The Seven-Billion Society: What's In It For Pharma?

By William Looney | Published: November 2, 2011
On Monday, the world’s population hit the 7 billion mark, repeating a pattern of largely unrestrained growth that has endured for the last century: the world is now adding roughly one billion people every 12 years. The UN Population Fund (UNPF) estimates that, barring some unforeseen demographic or environmental/development shifts, the figure will reach just [...]
Posted in Global, Op-Ed, healthcare | Also tagged , , , | 1 Comment

So, Where Are We with ACOs?

By Guest Blogger | Published: July 13, 2011
Tom Norton gets to grips with what an Accountable Care Organization is … and what it is not. Sixteen months into the new Healthcare Reform law, many continue to wonder about the status one of the most confused aspects of the new HCR — the elusive Accountable Care Organization, or ACO. And why are ACOs viewed [...]
Posted in Guest Blog, Regulatory | Also tagged , , , , | 2 Comments

Allergan Offers to Pay Journos to Discuss Botox

By Ben Comer | Published: May 11, 2011
Physicians aren’t the only ones getting paid to attend industry-sponsored events heavy on product discussions. For $250, “select” journalists can discuss facial aesthetics at an event sponsored by Botox-maker Allergan, on June 9 in New York City. Journalistic ethics can be checked at the door. The emailed invitation to attend Allergan’s Facial Aesthetics Advisory Panel, which [...]
Posted in Events, Strategy, Uncategorized | Also tagged , , | 1 Comment

Pharma Feels Delayed Effects of Economic Crisis

By Jennifer Ringler | Published: April 20, 2011
A new study from the IMS institute for Healthcare Informatics reveals that the spending increase on prescription medication in 2010 was the second-lowest increase in more than half a century. According to the IMS Institute for Healthcare Informatics, spending on prescription medications increased 2.3 percent in 2010 — a lower increase than the 5.1 percent [...]
Posted in healthcare | Also tagged , | Leave a comment

Governor Howard Dean: Financing the Future of US Drug Innovation

By William Looney | Published: April 6, 2011
Will it be More Good Pills — Or that Porsche? The Obama Administration’s signal achievement to date — passage of comprehensive health reform legislation — continues to inspire confusion and contradictions across the political spectrum. Despite its scope, the bill is dismissed by many Democrats for what it does not do, while the GOP [...]
Posted in FDA, R&D, Regulatory, healthcare | Also tagged , , , , | 1 Comment